Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Reviewing the Unmet Needs of Patients with Multiple Sclerosis.
Tecfidera(®): an approach for repurposing.
Effect of Rituximab in Patients With Leucine-Rich, Glioma-Inactivated 1 Antibody-Associated Encephalopathy.
Evaluating the response to glatiramer acetate in relapsing-remitting multiple sclerosis (RRMS) patients.
Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
Effects of an aqueous extract of North American ginseng on MOG((35-55))-induced EAE in mice.
The Antiaging Protein Klotho Enhances Oligodendrocyte Maturation and Myelination of the CNS.
Acorda Therapeutics announces issuance of additional U.S. Patent for AMPYRA® covering a range of dosage strengths
Efficacy and Tolerability of BAF312 in Patients With Polymyositis
Genzyme’s Lemtrada Recommended for Reimbursement on NHS by the National Institute for Health and Care Excellence (NICE)
Antiinflammatory effects of orientin-2″-o-galactopyranoside on lipopolysaccharide-stimulated microglia.
Quality of life and depression in multiple sclerosis patients: longitudinal results of the BetaPlus study.
Multiple sclerosis immunology: The healthy immune system vs the MS immune system.
Oxidative modification of serum proteins in multiple sclerosis.
Genmab announces positive top-line Phase II results of ofatumumab in multiple sclerosis
Fourth PML Case With Tecfidera in MS Calls for Vigilance
European Medicines Agency
LETHAL MULTIPLE SCLEROSIS RELAPSE AFTER NATALIZUMAB WITHDRAWAL.
Distinction and temporal stability of conformational epitopes on myelin oligodendrocyte glycoprotein recognized by patients with different inflammatory central nervous system diseases.
Peripheral B cell depletion and central proinflammatory cytokine reduction following repeated intrathecal administration of rituximab in progressive Multiple Sclerosis.
The Clinical Meaning of Walking Speed as Measured by the Timed 25-Foot Walk in Patients With Multiple Sclerosis.
Tobacco Smoke-Induced Brain White Matter Myelin Dysfunction: Potential Co-Factor Role of Smoking in Neurodegeneration.
Mitoxantrone-induced suicidal erythrocyte death.
Healthcare resource use and relapses with fingolimod versus natalizumab for treating multiple sclerosis: a retrospective US claims database analysis.
Soluble thrombomodulin levels in plasma of multiple sclerosis patients and their implication.

Pages